• Liver-expressed antimicrobial peptide 2 (LEAP2) is a 40-amino-acid hepatokine and acts as an endogenous antagonist/inverse agonist of the growth hormone secretagogue receptor (GHSR).
• Dynamic Assay Range: 0.064 ~ 8 ng/mL.
• Sensitivity: 20 pg/mL
• High Sensitivity Antibody Specific to human LEAP-2 (38-77) Peptide
• LEAP-2 (38-77) Peptide Biotinylated as Tracer
• Positive Control
• Assay Dilution Buffer Ready to Use
• Calibration: the mature human LEAP-2 (38-77) Peptide (disulfide bridges).
• Calibration Range: 0.064 ~ 40 ng/mL.
• Specificity: human and Mouse Bioactive LEAP-2 mature Peptide
• Luminescence Read on top
• Size: 96T, 192T ($980 per 192T) and 480T ($2250 per 480T).
• Extracted Samples for best recovery
• Storage: 12 months
• In-Vitro Research Use Only.
• Protocol of SK00007-06

• Liver-expressed antimicrobial peptide 2 (LEAP2) is a 40-amino-acid hepatokine and cationic antimicrobial peptide that acts as an endogenous antagonist/inverse agonist of the growth hormone secretagogue receptor (GHSR). It regulates energy homeostasis, appetite, and glucose metabolism by inhibiting ghrelin-mediated signaling. LEAP2 levels increase in obesity and decrease in energy-deficit states.

• 
  
  
  
  
  
  

Liver-expressed antimicrobial peptide 2 (LEAP2) is a 40-amino-acid hepatokine and cationic antimicrobial peptide that acts as an endogenous antagonist/inverse agonist of the growth hormone secretagogue receptor (GHSR). It regulates energy homeostasis, appetite, and glucose metabolism by inhibiting ghrelin-mediated signaling. LEAP2 levels increase in obesity and decrease in energy-deficit states.